Projekt
A dose blind, multicenter, extension study to determine the safety and efficasy of 2 doses of BG00012 monotherapy with Relapsin Remitting Multiple Sclerosis
Automatisch geschlossen · 2010 bis 2020
Müller Stefanie, Vehoff Jochen
Art
Reichweite
Bereiche
Status
Start
Ende
Finanzierungsart
Kurzbeschreibung/Zielsetzung
A dose blind, multicenter, extension study to determine the safety and efficasy of 2 doses of dimethyl fumarate (BG00012) monotherapy with Relapsin Remitting Multiple Sclerosis